James Hassard
Insider Reports History
- Location
- Pasadena, CA
- Signature
- Marc Wilson, as attorney-in-fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by James Hassard:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Chief Commercial Officer | Common Stock | 105,750 | $3,951,878 | $37.37 | 22 Jun 2021 | Direct |
| Crinetics Pharmaceuticals, Inc. | Chief Commercial Officer | Common Stock | 29,259 | $1,289,737 | $44.08 | 05 Jul 2024 | Direct |
| Crinetics Pharmaceuticals, Inc. | Chief Commercial Officer | Stock option (Right to Buy) | 130,000 | 05 Jul 2024 | Direct |
Insider Reports Filed by James Hassard
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals, Inc. | 05 Jul 2024 | 3 | -$365,250 | 4 | Chief Commercial Officer | 09 Jul 2024, 18:04 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 21 Jun 2024 | 3 | -$373,950 | 4 | Chief Commercial Officer | 24 Jun 2024, 17:08 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 18 Mar 2024 | 1 | -$66,402 | 4 | Chief Commercial Officer | 20 Mar 2024, 18:34 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 04 Mar 2024 | 2 | $0 | 4 | Chief Commercial Officer | 06 Mar 2024, 20:18 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 01 Mar 2023 | 2 | $0 | 4 | Chief Commercial Officer | 03 Mar 2023, 15:47 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 10 Mar 2022 | 1 | $0 | 4 | Chief Commercial Officer | 10 Mar 2022, 15:51 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 28 Feb 2022 | 0 | $0 | 3 | Chief Commercial Officer | 09 Mar 2022, 15:39 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 22 Jun 2021 | 1 | -$323,422 | 4 | Chief Commercial Officer | 24 Jun 2021, 18:44 |